🇺🇸
United States · US · US:0002-7797_60dc1045-5354-4f61-bf71-26129c6b07f4
EBGLYSS
UNIISPLATC D11AH10
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerEli Lilly and Company
CountryUS (United States)
ATC codeD11AH10
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 2
- ndc1100027797111 SYRINGE in 1 CARTON (0002-7797-11) / 2 mL in 1 SYRINGE (0002-7797-01)
- ndc1100027797611 SYRINGE in 1 CARTON (0002-7797-61) / 2 mL in 1 SYRINGE
Annotations
UNII (FDA Substance ID)
U9JLP7V031
LEBRIKIZUMAB
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "U9JLP7V031",
"rxcui": null,
"inchikey": null,
"display_name": "LEBRIKIZUMAB",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"7a774ea2-acde-4aaa-9a8f-ccba5a5b1d5f": {
"match": "brand_token",
"title": "EBGLYSS (LEBRIKIZUMAB-LBKZ) INJECTION, SOLUTION [ELI LILLY AND COMPANY]",
"spl_version": "12",
"published_date": "2026-05-21"
}
},
"productid": "0002-7797_60dc1045-5354-4f61-bf71-26129c6b07f4",
"productndc": "0002-7797",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "LEBRIKIZUMAB",
"proprietary_name": "EBGLYSS",
"active_ingred_unit": "mg/2mL",
"application_number": "BLA761306",
"marketing_category": "BLA",
"nonproprietary_name": "lebrikizumab-lbkz",
"start_marketing_date": "20240913",
"active_numerator_strength": "250"
}Related drugs
Other records sharing ATC code D11AH10.
Access this data programmatically
Query EBGLYSS and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.